본문 바로가기
KERD
논문KCI 등재

MTHFR C677T 유전자 다형성과 다발성 뇌경색 환자군에서의 비교위험도 분석

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류신경과학

초록

Department of Neurology, and Institute for Clinical Research* College of Medicine Pochon CHA University Background & Objectives : Hyperhomocysteinemia has been known to be an independent risk factor for cerebrovascular disease. Elevated plasma homocysteine levels can result from defective remethylation of homocysteine to methionine due to decreased activity of the enzyme, methylenetetrahydrofolate reductase(MTHFR). A genetic aberration in the MTHFR gene has been shown to result in reduced MTHFR activity. However, study results examining the association between the C677T MTHFR mutation and ischemic stroke are still controversial. This study was undertaken to determine whether the C677T MTHFR gene mutation was associated with particular subtypes of ischemic stroke. Methods : The case group consisted of 129 patients with ischemic stroke and the control group consisted of 157 healthy individuals. Total plasma homocysteine level was determined by radioenzymatic method. A segment of the MTHFR was tested by polymerase chain reaction with restriction enzyme, HinfI. The diagnosis of cerebral infarction of all study patients was confirmed by MRI of the brain. Results : The homocysteine level in plasma was significantly higher in ischemic stroke patients 10.38±6.44 μmol/L) than in controls(8.00±2.40)(P<0.05). It was also high in patients with the multiple infarction(11.57±7.38)(P<0.05). On the other hand, the prevalence of the homozygote mutation was not significantly higher in ischemic stroke patients(20.2%) than in controls(13.4%)(adjusted OR 1.39, 95% CI 0.65 to 2.96). The odds ratio and 95% confidence intervals adjusted for the other risk factors was 2.73(1.09 to 6.85) for the TT genotype in patients with the multiple infarction(28.0%) compared to controls. The 677TT genotype was increased in the multiple infarction compared to the single infarction(9.3%)(adjusted OR 3.80, 95% CI 1.07 to 13.56). Conclusions : Our findings suggest that the MTHFR homozygote mutation(677TT) maay be a risk predictor for a certain subtype of ischemic stroke, such as the multiple infarction. Korean Journal of Stroke 2002;4(1): 18~24

Abstract

Department of Neurology, and Institute for Clinical Research* College of Medicine Pochon CHA University Background & Objectives : Hyperhomocysteinemia has been known to be an independent risk factor for cerebrovascular disease. Elevated plasma homocysteine levels can result from defective remethylation of homocysteine to methionine due to decreased activity of the enzyme, methylenetetrahydrofolate reductase(MTHFR). A genetic aberration in the MTHFR gene has been shown to result in reduced MTHFR activity. However, study results examining the association between the C677T MTHFR mutation and ischemic stroke are still controversial. This study was undertaken to determine whether the C677T MTHFR gene mutation was associated with particular subtypes of ischemic stroke. Methods : The case group consisted of 129 patients with ischemic stroke and the control group consisted of 157 healthy individuals. Total plasma homocysteine level was determined by radioenzymatic method. A segment of the MTHFR was tested by polymerase chain reaction with restriction enzyme, HinfI. The diagnosis of cerebral infarction of all study patients was confirmed by MRI of the brain. Results : The homocysteine level in plasma was significantly higher in ischemic stroke patients 10.38±6.44 μmol/L) than in controls(8.00±2.40)(P<0.05). It was also high in patients with the multiple infarction(11.57±7.38)(P<0.05). On the other hand, the prevalence of the homozygote mutation was not significantly higher in ischemic stroke patients(20.2%) than in controls(13.4%)(adjusted OR 1.39, 95% CI 0.65 to 2.96). The odds ratio and 95% confidence intervals adjusted for the other risk factors was 2.73(1.09 to 6.85) for the TT genotype in patients with the multiple infarction(28.0%) compared to controls. The 677TT genotype was increased in the multiple infarction compared to the single infarction(9.3%)(adjusted OR 3.80, 95% CI 1.07 to 13.56). Conclusions : Our findings suggest that the MTHFR homozygote mutation(677TT) maay be a risk predictor for a certain subtype of ischemic stroke, such as the multiple infarction. Korean Journal of Stroke 2002;4(1): 18~24

관련 논문AI추천

뇌경색 환자에서 고호모시스테인혈증과 C677T MTHER 유전자 다형성의 상관 관계김남근, 김상범, 김선희, 김옥준, 김현조, 서정호, 오도연, 이규용, 정경천, 정보우, 최병옥대한신경과학회 · 대한신경과학회지2002 · 제20권 제4호Association of Methylenetetrahydrofolate Reductase (MTHFR 677C>T and 1298A>C) Polymorphisms and Haplotypes with Silent Brain Infarction and Homocysteine Levels in a Korean Population허륭, 김남근, 김옥준, 안정용, 오도연, 정상섭, 한인보, 홍순표연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제2호Influence of Combined Methionine Synthase (MTR 2756A>G) and Methylenetetrahydrofolate Reductase (MTHFR 677C>T) Polymorphisms to Plasma Homocysteine Levels in Korean Patients with Ischemic Stroke김남근, 김수옥, 김옥준, 안정용, 오도연, 유왕돈, 홍선표, 홍승호, 황태선연세대학교의과대학 · Yonsei Medical Journal2007 · 제48권 제2호MTHFR C677T 유전자 다형성과 허혈성 뇌졸중의 상관 관계김숙희, 김지영, 김희진, 박기덕, 윤지영, 이정화, 조현지, 최경규, 최병옥대한신경과학회 · 대한신경과학회지2005 · 제23권 제5호뇌졸중후 우울증에서 호모시스테인의 역할김옥준대한뇌졸중학회 · 대한뇌졸중영문학회지2003 · 제5권 제1호MTHFR유전자의 이형접합변이(C677T)를 동반한 대뇌정맥동혈전증채솔, 윤동민, 임성민, 장상현대한신경과학회 · 대한신경과학회지2022 · 제40권 제4호

이 간행물의 다른 논문 (12건)